We are pleased to announce that CircleLink recently raised a $2.5M equity financing led by Fresco Capital with participation from Vivek Garipalli. This capital will help expand product lines and sales channels, to further our mission of improving chronic condition outcomes and reducing healthcare costs. Existing partners joining the recent round were Newark Venture Partners, I2BF Global Ventures and FundersClub.
We could not be happier with these investors. Fresco brings extensive venture investment experience, including multiple digital health exits. Their thesis on the future of work also makes them a perfect fit with our remote work tele-nursing platform. Vivek’s operating experience is just as impactful: Founder/CEO of Clover Health and CarePoint, and a founding board member of Flatiron Health. As part of the transaction, Vivek’s investing partner, Luke Boyett, will be joining the board of CircleLink. Luke brings a decade of healthcare experience at Humana, most recently as VP of Corporate Finance and M&A, where he led multiple transactions and investments around value-based care and chronic care management themes. Allison Baum, co-founder and Managing Partner at Fresco Capital, will also be joining the board.
With these resources and expertise, we’re energized to continue building a world-class preventative care platform to improve health, reduce costs, and accelerate the transition to fee-for-value.
About: CircleLink is an online platform and telephone nurse service using data and product to better remotely manage patients with chronic and behavioral conditions between doctor visits, on behalf of those doctors ($10B addressable market).
Through our Chronic Care Management (CCM) and Behavioral Health Integration (BHI) solutions, providers can improve health and earn new Medicare payments (up to $60K/year per doctor). CircleLink makes it easy by handling patient targeting, enrollment, and integration with various EHRs so doctors can stay on one system. CircleLink uses 100% registered nurses for meaningful remote patient engagement on doctors’ behalf.